BVS
BVS
NASDAQ · Health Care

Bioventus Inc - A

$8.94
-0.32 (-3.46%)
As of Mar 29, 10:17 PM ET ·
Financial Highlights (FY 2026)
Revenue
736.78M
Net Income
-43,104,243
Gross Margin
67.7%
Profit Margin
-5.9%
Rev Growth
+10.0%
D/E Ratio
2.34
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 45.6% 45.6%
Operating Margin -2.1% -1.9% 15.0% 14.8%
Profit Margin -5.9% -5.6% 14.9% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 736.78M 669.92M 241.82M 197.18M
Gross Profit 498.95M 453.67M 110.34M 89.97M
Operating Income -15,398,679 -12,601,210 36.38M 29.11M
Net Income -43,104,243 -35,273,521 36.10M 22.67M
Gross Margin 67.7% 67.7% 45.6% 45.6%
Operating Margin -2.1% -1.9% 15.0% 14.8%
Profit Margin -5.9% -5.6% 14.9% 11.5%
Rev Growth +10.0% +10.0% -4.8% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 248.72M 248.72M 254.88M 304.50M
Total Equity 106.34M 106.34M 321.56M 308.93M
D/E Ratio 2.34 2.34 0.79 0.99
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,126,717 -4,428,424 52.99M 46.00M
Free Cash Flow 25.01M 12.86M